Hyderabad: List of Emergency Use (EUL) from Covid-19 Vaccine Bharat Biotech Covaxin by the World Health Organization (WHO) Not a long-drawn process as the majority of vaccine maker facilities have been audited by Global Health Body, Suchitra Ella, Director of Executing with Bharat Biotech, said on Wednesday.
We work closely with the World Health Organization for the inclusion of Covaxin in the list of emergency use.
Approval from who is not expected to be a long-drawn process because of the cell line and the majority of our facilities have been audited and approved by whom for our other vaccine in the past, Ella said in a tweet.
He further said the EUL process was closer to the final decision about Covaxin’s global acceptance because the data rolling was scheduled to start next month.
With 10 scientific publications in 12 months, Covaxin is one of the few vaccines that have extensive data published in the journal peer-reviewed globally, he said.
Our vision rarely changes, of course, until our last mission is finished #Covaxin.
We ensure to continue the EUL process in accordance with the universal regulatory guidelines & schedule for Covid-19 vaccine.
We will keep you posted every step in front, he is tweeted.